SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer
Authors:
- 5 February 2022
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 41 (12) , 1767-1779
Abstract
Müllerian tissue-specific oncogenes, prototyped by PAX8, underlie ovarian tumorigenesis and represent unique molecular vulnerabilities. Further delineating such lineage-dependency factors and associated therapeutic implications would provide valuable insights into ovarian cancer biology and treatment. In this study, we identified SOX17 as a new lineage-survival master transcription factor, which shared co-expression pattern with PAX8 in epithelial ovarian carcinoma. Genetic disruption of SOX17 or PAX8 analogously inhibited neoplastic cell viability and downregulated a spectrum of lineage-related transcripts. Mechanistically, we showed that SOX17 physically interacted with PAX8 in cultured cell lines and clinical tumor specimens. The two nuclear proteins bound to overlapping genomic regions and regulated a common set of downstream genes, including those involved in cell cycle and tissue morphogenesis. In addition, we revealed that small-molecule inhibitors of transcriptional cyclin-dependent kinases (CDKs) effectively reduced SOX17 and PAX8 expression. ZSQ1722, a novel orally bioavailable CDK12/13 covalent antagonist, exerted potent anti-tumor activity in xenograft models. These findings shed light on an actionable lineage-survival transcriptional complex in ovarian cancer, and facilitated drug discovery by generating a serial of candidate compounds to pharmacologically target this difficult-to-treat malignancy.Keywords
This publication has 49 references indexed in Scilit:
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitorNature, 2014
- Pax genes: regulators of lineage specification and progenitor cell maintenanceDevelopment, 2014
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell LymphomaCancer Cell, 2013
- Sox proteins: regulators of cell fate specification and differentiationDevelopment, 2013
- FGF18 as a prognostic and therapeutic biomarker in ovarian cancerJournal of Clinical Investigation, 2013
- Transcriptional Regulation and Its Misregulation in DiseaseCell, 2013
- The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell FateCell Stem Cell, 2013
- Transcription factors: from enhancer binding to developmental controlNature Reviews Genetics, 2012
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerProceedings of the National Academy of Sciences, 2011
- Lineage dependency and lineage-survival oncogenes in human cancerNature Reviews Cancer, 2006